Dinesh Khanna1,2, Ron D Hays3,4, Andrew B Shreiner5, Gil Y Melmed6, Lin Chang7,8, Puja P Khanna9, Roger Bolus10,11, Cynthia Whitman11, Sylvia H Paz3,4, Tonya Hays3,4, Steven P Reise12, Brennan Spiegel13,14,15,16,17. 1. Division of Rheumatology, University of Michigan, 1500 E. Medical Center Dr., SPC 5370, Ann Arbor, MI, 48109, USA. khannad@med.umich.edu. 2. Division of Rheumatology/Department of Internal Medicine, University of Michigan Scleroderma Program, 300 North Ingalls Street, Suite 7C27, Ann Arbor, MI, 48109, USA. khannad@med.umich.edu. 3. Division of General Internal Medicine & Health Services Research, David Geffen School of Medicine at UCLA, 911 Broxton Avenue, Los Angeles, CA, 90024, USA. 4. Department of Health Policy and Management, UCLA Fielding School of Public Health, 911 Broxton Avenue, Los Angeles, CA, 90024, USA. 5. Division of Gastroenterology, University of Michigan, 1500 E. Medical Center Dr., SPC 5362, Ann Arbor, MI, 48109-5362, USA. 6. Department of Gastroenterology, Cedars-Sinai Medical Center, 8730 Alden Dr., Los Angeles, CA, 90048, USA. 7. Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 8. G. Oppenheimer Family Center for Neurobiology of Stress and Resilience, David Geffen School of Medicine at UCLA, 100 UCLA Medical Plaza, Los Angeles, CA, 90095, USA. 9. Division of Rheumatology, University of Michigan, 1500 E. Medical Center Dr., SPC 5370, Ann Arbor, MI, 48109, USA. 10. Department of Gastroenterology, VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA. 11. UCLA/VA Center for Outcomes Research and Education (CORE), 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA. 12. UCLA Department of Psychology, 3857 Franz Hall, Los Angeles, CA, 90095, USA. 13. Division of General Internal Medicine & Health Services Research, David Geffen School of Medicine at UCLA, 911 Broxton Avenue, Los Angeles, CA, 90024, USA. Brennan.Spiegel@cshs.org. 14. Department of Health Policy and Management, UCLA Fielding School of Public Health, 911 Broxton Avenue, Los Angeles, CA, 90024, USA. Brennan.Spiegel@cshs.org. 15. Department of Gastroenterology, VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA. Brennan.Spiegel@cshs.org. 16. UCLA/VA Center for Outcomes Research and Education (CORE), 11301 Wilshire Blvd., Los Angeles, CA, 90073, USA. Brennan.Spiegel@cshs.org. 17. Medicine and Public Health, Division of Health Services Research, Cedars-Sinai Health System, Cedars-Sinai and UCLA, 8723 W. Alden Drive, Steven Spielberg Building, Los Angeles, CA, 90048, USA. Brennan.Spiegel@cshs.org.
Abstract
BACKGROUND: The NIH-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal (GI) Symptoms scales were developed to assess patients' GI symptoms in clinical settings. AIMS: To assess responsiveness to change and provide minimally important difference (MID) estimates for the PROMIS GI Symptoms scales. METHODS: A sample of 256 GI outpatients self-administered the eight PROMIS GI Symptoms scales (gastroesophageal reflux, disrupted swallowing, diarrhea, bowel incontinence/soilage, nausea and vomiting, constipation, belly pain, and gas/bloating/flatulence) at two visits. Patient self-reported and physician-reported assessments of the subjects' overall GI condition were employed as change anchors. In addition, we prospectively assessed change at both visits using a GI-symptom anchor, the Gastrointestinal Symptom Rating Scale (GSRS). Responsiveness to change was assessed using F-statistics. The minimally changed group was those somewhat better or somewhat worse on the retrospective anchors and changing by one category on the modified GSRS (e.g., from slight to mild discomfort to moderate to moderately severe discomfort). RESULTS: Responsiveness to change was statistically significant for 6 of 8 PROMIS scales using the self-report GI anchor, 3 of 8 scales using the physician-reported anchor, and 5 of 5 scales using the corresponding GSRS scales as anchors. The MID estimates for scales for improvement and worsening were about 0.5-0.6 SD using the GSRS anchor and generally larger in magnitude than the change for the "about the same" group. CONCLUSIONS: The responsiveness and MID estimates provided here for the PROMIS GI Symptoms scales can aid in scale score interpretation in clinical trials and observational studies.
BACKGROUND: The NIH-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal (GI) Symptoms scales were developed to assess patients' GI symptoms in clinical settings. AIMS: To assess responsiveness to change and provide minimally important difference (MID) estimates for the PROMIS GI Symptoms scales. METHODS: A sample of 256 GI outpatients self-administered the eight PROMIS GI Symptoms scales (gastroesophageal reflux, disrupted swallowing, diarrhea, bowel incontinence/soilage, nausea and vomiting, constipation, belly pain, and gas/bloating/flatulence) at two visits. Patient self-reported and physician-reported assessments of the subjects' overall GI condition were employed as change anchors. In addition, we prospectively assessed change at both visits using a GI-symptom anchor, the Gastrointestinal Symptom Rating Scale (GSRS). Responsiveness to change was assessed using F-statistics. The minimally changed group was those somewhat better or somewhat worse on the retrospective anchors and changing by one category on the modified GSRS (e.g., from slight to mild discomfort to moderate to moderately severe discomfort). RESULTS: Responsiveness to change was statistically significant for 6 of 8 PROMIS scales using the self-report GI anchor, 3 of 8 scales using the physician-reported anchor, and 5 of 5 scales using the corresponding GSRS scales as anchors. The MID estimates for scales for improvement and worsening were about 0.5-0.6 SD using the GSRS anchor and generally larger in magnitude than the change for the "about the same" group. CONCLUSIONS: The responsiveness and MID estimates provided here for the PROMIS GI Symptoms scales can aid in scale score interpretation in clinical trials and observational studies.
Authors: Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel Journal: Am J Gastroenterol Date: 2013-12-17 Impact factor: 10.864
Authors: Dinesh Khanna; Daniel E Furst; Paul Maranian; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Terri Getzug; Ron D Hays Journal: J Rheumatol Date: 2011-07-01 Impact factor: 4.666
Authors: Brennan M R Spiegel; Ron D Hays; Roger Bolus; Gil Y Melmed; Lin Chang; Cynthia Whitman; Puja P Khanna; Sylvia H Paz; Tonya Hays; Steve Reise; Dinesh Khanna Journal: Am J Gastroenterol Date: 2014-09-09 Impact factor: 10.864
Authors: L G Bordeianou; J Anger; M Boutros; E Birnbaum; J C Carmichael; K Connell; E J B De; A Mellgren; K Staller; S A Vogler; M M Weinstein; F A Yafi; T Hull Journal: Tech Coloproctol Date: 2019-12-11 Impact factor: 3.781
Authors: Phoebe Heenan; Rob H Creemers; Shriya Sharma; Jacqueline Keenan; Simone Bayer; Wayne Young; Janine Cooney; Kelly Armstrong; Karl Fraser; Paula M Skidmore; Nicholas J Talley; Nicole Roy; Richard B Gearry Journal: Inflamm Intest Dis Date: 2020-07-08
Authors: D M Evon; J Amador; P Stewart; B B Reeve; A S Lok; R K Sterling; A M Di Bisceglie; N Reau; M Serper; S Sarkar; J K Lim; C E Golin; M W Fried Journal: Aliment Pharmacol Ther Date: 2018-01-29 Impact factor: 8.171
Authors: Donna M Evon; Hannah P Kim; Angela Edwards; Jessica Carda-Auten; Bryce B Reeve; Carol E Golin; Michael W Fried Journal: Dig Dis Sci Date: 2021-02-02 Impact factor: 3.199
Authors: Donna M Evon; Souvik Sarkar; Jipcy Amador; Anna S Lok; Richard K Sterling; Paul W Stewart; Bryce B Reeve; Marina Serper; Nancy Reau; K Rajender Reddy; Adrian M Di Bisceglie; David R Nelson; Carol E Golin; Joseph K Lim; Michael W Fried Journal: J Hepatol Date: 2019-05-13 Impact factor: 30.083
Authors: Suzanne Kafaja; Philip J Clements; Holly Wilhalme; Chi-Hong Tseng; Daniel E Furst; Grace Hyun Kim; Jonathan Goldin; Elizabeth R Volkmann; Michael D Roth; Donald P Tashkin; Dinesh Khanna Journal: Am J Respir Crit Care Med Date: 2017-11-03 Impact factor: 30.528
Authors: Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen Journal: Qual Life Res Date: 2020-08-19 Impact factor: 4.147
Authors: Marina Serper; Donna M Evon; Jipcy Amador; Paul W Stewart; Souvik Sarkar; Anna S Lok; Richard K Sterling; Bryce B Reeve; Carol E Golin; K Rajender Reddy; Joseph K Lim; Nancy Reau; David R Nelson; Adrian M Di Bisceglie; Michael W Fried Journal: Liver Int Date: 2021-01-22 Impact factor: 5.828
Authors: Cleo A Samuel; Angela B Smith; Wendi Elkins; Jennifer Richmond; Zahra Mahbooba; Ethan Basch; Antonia V Bennett; Arlene E Chung; Mattias Jonsson; Ronald C Chen; Bryce B Reeve Journal: Qual Life Res Date: 2020-02-28 Impact factor: 3.440